-
-
Jolly, you wouldn't be picking this apart if it weren't me posting it. I just posted some facts.
Can't you just let it go?
Actually, I'd pick it apart whomever posted it.
Furthermore, it's not picking it apart. I'm looking at the basic facts for any medical supply chain, and why, or why not, medical companies choose to make anything.
-
"Sorry to hear about your husband" would have been nice as a preface.
But as they say, whatever.
Whatever.
- I either don't know or do not remember your husband has bladder cancer.
- I do know Larry has bladder cancer.
- My grandmother died from bladder cancer.
I wouldn't have changed one word of what I said. Healthcare is always about supply and demand, and trying to deliver the best care to the most people we can. Sometimes, that means some very hard choices...I've told the story before of standing in the middle of a quick conversation between two docs who were trying to handle three simultaneous codes with only enough staff and equipment for two.
That's life. That's real.
And if having a treatment that will spare thousands or millions of lives, at the expense of older people with cancer, that's going to be a tough choice we'll have to make. Hopefully, if BCG has some effectiveness, we can ramp up production quickly and no more need die than absolutely have to.
-
@wtg Whoa! I missed this along the way. I'm very sorry to hear this about your husband. If the drug is promising at all, it's time for production to ramp up, especially if there are users already in place. If it turns out to not be the great thing for the virus, it can still get used by others.
-
"Now look here, you Baltic gas passer... " - Mik, 6/14/08
The saying, "Lite is just one damn thing after another," is a gross understatement. The damn things overlap.
-
The BCG vaccination administered during childhood does not protect against COVID-19 in adulthood, a new study by researchers at Tel Aviv University, published in the Journal of the American Medical Association has concluded, according to The Hindu.
The finding is significant as a previous study, yet to be peer reviewed, found that countries which had universal childhood BCG vaccination programs had fewer coronavirus cases and deaths than countries which did not have a vaccination program, suggesting that the BCG vaccination had conferred protection again COVID-19.
Israel's population served as an excellent natural sample for the study, as a national immunization program which ran from 1955 until 1982 ensured that children born in Israel were routinely given the BCG vaccination. However, since 1982 only immigrants from countries with high prevalence of tuberculosis have been given the vaccination. Researchers were therefore able to compare the rate of coronavirus infection in the two groups.
Original article from JAMA is here: https://jamanetwork.com/journals/jama/fullarticle/2766182?resultClick=1
